Free press releases distribution network?

Agency / Source: M Booth and Associates

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Image Solutions, Inc. Appoints Director of Regulatory Strategy - Image Solutions, Inc. (ISI), a leading provider of software and services to the life sciences industry, today announced that it has appointed Lisa Jenkins, Ph.D., to the position of Director of Regulatory Strategy
Image Solutions, Inc. Appoints Director of Regulatory Strategy

 

PRZOOM - /newswire/ - Whippany, NJ, United States, 2010/03/23 - Image Solutions, Inc. (ISI), a leading provider of software and services to the life sciences industry, today announced that it has appointed Lisa Jenkins, Ph.D., to the position of Director of Regulatory Strategy.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Jenkins joins the company’s professional services unit – a global team that includes former biopharmaceutical industry professionals experienced in guiding companies through each phase of development. She will advise clients on all aspects of clinical development and global strategic regulatory affairs. The appointment adds muscle to ISI’s growing professional services business and enhances the company’s broad range of offerings in regulatory consulting.

With more than 10 years experience in industry, Dr. Jenkins’s background includes product development planning, global regulatory submission strategy, dossier preparation and submission, and post-approval life-cycle management. She specializes in product labeling activities and risk management planning, and has also served as U.S. Agent for several clients and performed routine regulatory maintenance activities. She has led global, cross-functional teams to bring new, innovative therapies to market. Prior to her position at ISI, Dr. Jenkins served as a Principal Statistician and Senior Manager of Regulatory Affairs at Wyeth, and most recently, as Associate Director and Regulatory Group Leader with Kendle International, Inc.

“Pharmaceutical and biotechnology companies are looking for seasoned counsel to help them navigate the highly complex and ever-changing regulatory environment. We are pleased to welcome Lisa and to be able to leverage her deep submissions- experience and unique quantitative background across our client base – from our emerging company clients seeking advice on their development strategies to large global organizations exploring options to penetrate new emerging markets,” said Kenneth VanLuvanee, Vice President of Global Professional Services at ISI.

ISI’s expansion of the team comes at a crucial inflection point for industry. Many biopharmaceutical companies are determining their regulatory strategies in an environment where they must more stringently manage risk and maximize their product portfolio value. Dr. Jenkins will be working with a team that helps companies more effectively manage interactions with regulatory agencies, produce world-class submissions, and define and deliver the most efficient paths to market approval.

“Our clients are nearly as varied as the people they aim to help. That is why ISI’s approach of providing adaptable roadmaps founded in strategic consulting and software was so appealing to me,” said Dr. Jenkins. “Regardless of the organization’s desired strategy, ISI’s vision is to form lasting strategic partnerships with our clients to help them most efficiently navigate through the product development, regulatory submission, and post-approval process.”

Dr. Jenkins maintains a number of professional affiliations, including the Drug Information Association (DIA) and the Regulatory Affairs Professionals Society (RAPS) and is an active member of DIA’s Drug Information Journal Editorial Board. Over the last decade, Dr. Jenkins has been published in a multitude of peer-reviewed industry journals, including Global Forum, Neurology, Journal of Neurology, Psychology and Aging. Her most recent publications have provided guidance on how Sponsors can make the most out of their regulatory agency meetings. She has presented at numerous industry conferences, including RAPS Annual Meetings and DIA Annual Meetings.

Dr. Jenkins joins ISI with a diverse background that includes time spent at the University of North Carolina-Wilmington as a research psychologist studying normal and diseased aging. It was during her term as the Senior Manager of Regulatory Affairs at Wyeth that she gained much of her invaluable experience, receiving the Wyeth Team of the Year Award twice and the Above and Beyond Award four times in a six year stretch. During her tenure at Kendle International, Inc., serving in the roles of Associate Director and Regulatory Group Leader, Dr. Jenkins led numerous New Drug Application (NDA) and Biologic License Application (BLA) teams which resulted in successful U.S. filings and one first cycle approval in 2009.

About ISI
Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI (imagesolutions.com) was among the first professional services firms to deliver electronic submissions to the industry and since has delivered thousands of electronic and eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognised charitable organisations.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: M Booth and Associates

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Image Solutions, Inc. Appoints Director of Regulatory Strategy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Josh Pope - MBooth.com 
212-539-3277 JoshP[.]mbooth.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any M Booth and Associates securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From M Booth and Associates / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today